BACKGROUND/AIMS: Deregulation of cell cycle control is a hallmark of cancer. The primary cyclins (A, B1, D1, D3, and E) are crucial for cell cycle progression. Secondary cyclins (C and H) have putative indirect effects on cell cycle progression and have not previously been evaluated in colon cancer. This study examined cyclin protein expression and gene amplification in colon adenocarcinoma and the correlation with patient outcome. METHODS: Immunohistochemistry and real time quantitative polymerase chain reaction were used to determine cyclin expression and gene amplification in 219 tumours. The results were compared with clinical variables and patient outcomes. RESULTS: Cyclin H was overexpressed in all tumours, cyclin C in 88%, cyclin B1 in 58%, cyclin A in 83%, cyclin D3 in 36%, cyclin E in 25%, and cyclin D1 in 11% of the tumours. Extra gene copies of cyclin A were seen in 6.2% of the tumours, cyclin B1 in 9%, cyclin C in 26.9%, cyclin D1 in 55%, cyclin D3 in 20.5%, cyclin E in 19.1%, and cyclin H in 5.1%. A significant correlation between protein overexpression and gene amplification was seen for cyclin C only. High expression of cyclin A was independently associated with improved survival. Amplification of cyclin C was independently associated with an unfavourable prognosis. CONCLUSIONS: Amplification of the cyclin C gene was related to an unfavourable prognosis and high protein expression of cyclin A was associated with a better outcome in colon adenocarcinoma.
BACKGROUND/AIMS: Deregulation of cell cycle control is a hallmark of cancer. The primary cyclins (A, B1, D1, D3, and E) are crucial for cell cycle progression. Secondary cyclins (C and H) have putative indirect effects on cell cycle progression and have not previously been evaluated in colon cancer. This study examined cyclin protein expression and gene amplification in colon adenocarcinoma and the correlation with patient outcome. METHODS: Immunohistochemistry and real time quantitative polymerase chain reaction were used to determine cyclin expression and gene amplification in 219 tumours. The results were compared with clinical variables and patient outcomes. RESULTS:Cyclin H was overexpressed in all tumours, cyclin C in 88%, cyclin B1 in 58%, cyclin A in 83%, cyclin D3 in 36%, cyclin E in 25%, and cyclin D1 in 11% of the tumours. Extra gene copies of cyclin A were seen in 6.2% of the tumours, cyclin B1 in 9%, cyclin C in 26.9%, cyclin D1 in 55%, cyclin D3 in 20.5%, cyclin E in 19.1%, and cyclin H in 5.1%. A significant correlation between protein overexpression and gene amplification was seen for cyclin C only. High expression of cyclin A was independently associated with improved survival. Amplification of cyclin C was independently associated with an unfavourable prognosis. CONCLUSIONS: Amplification of the cyclin C gene was related to an unfavourable prognosis and high protein expression of cyclin A was associated with a better outcome in colon adenocarcinoma.
Authors: K Kitahara; W Yasui; H Kuniyasu; H Yokozaki; Y Akama; S Yunotani; T Hisatsugu; E Tahara Journal: Int J Cancer Date: 1995-07-04 Impact factor: 7.396
Authors: Rolf Aamodt; Kristin Jonsdottir; Solveig Norheim Andersen; Johan Bondi; Geir Bukholm; Ida R K Bukholm Journal: Gastroenterol Res Pract Date: 2009-12-15 Impact factor: 2.260
Authors: Jose Perea; Edurne Alvaro; Yolanda Rodríguez; Cristina Gravalos; Eva Sánchez-Tomé; Barbara Rivera; Francisco Colina; Pablo Carbonell; Rogelio González-Sarmiento; Manuel Hidalgo; Miguel Urioste Journal: World J Gastroenterol Date: 2010-08-07 Impact factor: 5.742
Authors: Sonia I Vlaicu; Cosmin A Tegla; Cornelia D Cudrici; Matthew Fosbrink; Vingh Nguyen; Philippe Azimzadeh; Violeta Rus; Hegang Chen; Petru A Mircea; Abulkalam Shamsuddin; Horea Rus Journal: Exp Mol Pathol Date: 2009-10-31 Impact factor: 3.362
Authors: Shuji Ogino; Katsuhiko Nosho; Natsumi Irahara; Shoko Kure; Kaori Shima; Yoshifumi Baba; Saori Toyoda; Li Chen; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs Journal: Clin Cancer Res Date: 2009-06-23 Impact factor: 12.531
Authors: Na Li; Anne Fassl; Joel Chick; Hiroyuki Inuzuka; Xiaoyu Li; Marc R Mansour; Lijun Liu; Haizhen Wang; Bryan King; Shavali Shaik; Alejandro Gutierrez; Alban Ordureau; Tobias Otto; Taras Kreslavsky; Lukas Baitsch; Leah Bury; Clifford A Meyer; Nan Ke; Kristin A Mulry; Michael J Kluk; Moni Roy; Sunkyu Kim; Xiaowu Zhang; Yan Geng; Agnieszka Zagozdzon; Sarah Jenkinson; Rosemary E Gale; David C Linch; Jean J Zhao; Charles G Mullighan; J Wade Harper; Jon C Aster; Iannis Aifantis; Harald von Boehmer; Steven P Gygi; Wenyi Wei; A Thomas Look; Piotr Sicinski Journal: Nat Cell Biol Date: 2014-10-26 Impact factor: 28.824